Trademark Overview
On Thursday, January 16, 2025, a trademark application was filed for HYDROXYMED with the United States Patent and Trademark Office. The USPTO has given the HYDROXYMED trademark a serial number of 99002566. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 16, 2025. This trademark is owned by Right2Try Inc.. The HYDROXYMED trademark is filed in the Pharmaceutical Products category with the following description:
A chemical formulation comprising hydroxychloroquine for use in targeting malignant cells by inhibiting drug resistance, improving chemotherapy cell penetration, potentiation of presentation of major histocompatibility complexes, intercalating directly into DNA; a chemical formulation comprising hydroxychloroquine for use in tempering severe systemic inflammatory responses to filoviruses through dysregulation of lysosomes and lysosomal pH through decreased production of tumor necrosis factor alpha and interferon; a chemical formulation comprising hydroxychloroquine for use in preventing toll-like receptor activation by binding directly to nucleic acids in the activation pathway and lowering the body's primary cell-mediated inflammatory response.
